Posts

Drug Container Interactions: Why Packaging Must Be Treated as a Critical Quality Attribute Across the Product Lifecycle

Image
  Introduction Pharmaceutical packaging has traditionally been viewed as a downstream activity selected after formulation and process development are finalized. However, increasing scientific evidence and regulatory expectations have demonstrated that packaging is not a passive component. Instead, it is an integral part of the drug product system that can significantly influence quality, safety, and efficacy. Drug container interactions can lead to chemical, physical, or biological changes in the product, making packaging a Critical Quality Attribute (CQA) that must be addressed throughout the product lifecycle. Key Drug–Container Interaction Mechanisms 1. Silicone Oil Interactions Silicone oil is widely used as a lubricant in prefilled syringes and cartridges. Nonuniform silicone distribution and silicone droplet formation can contribute to protein aggregation, subvisible particles, and dose variability. Interaction between silicone and biologics is a growing concern fo...
Post a Comment
Read more

Pharmaceutical Packaging 4.0: Smart, Connected, and Data Driven Solutions for the Future

Image
  Pharmaceutical Packaging 4.0: Smart, Connected, and Data Driven Solutions for the Future Pharmaceutical packaging has come a long way from being just a protective shell for medicines. Today, it is increasingly  intelligent, connected, and data driven , reflecting the broader digital transformation in the pharma industry. The emergence of  Packaging 4.0  represents a paradigm shift, combining traditional protective functions with advanced technology, real time monitoring, and predictive analytics. In my upcoming book,  Pharmaceutical Primary Packaging , set to be available by the  third week of February , I explore the evolution of pharmaceutical packaging in depth from materials and barrier performance to intelligent, smart packaging solutions. This blog provides a focused view on  Packaging 4.0 , highlighting its technologies, benefits, challenges, and future outlook. What is Packaging 4.0? Packaging 4.0 can be defined as the integra...
Post a Comment
Read more
Image
  Current Challenges in Pharmaceutical Blister Packaging in Egypt: A Technical Deep Dive Pharmaceutical blister packaging is the backbone of oral solid dosage manufacturing in Egypt, ensuring product protection, regulatory compliance, and patient safety. While the global industry continues moving toward sustainable, high-barrier, and machine-optimized materials, Egypt’s blister packaging ecosystem is navigating a mix of legacy systems, supply-chain constraints, and climatic challenges unique to the country. This blog presents a technical and detailed analysis of the current issues affecting blister packaging manufacturers in Egypt—covering materials, machinery, stability, regulations, and quality control. 1. Heavy Dependence on Imported High-Barrier Materials Egypt’s domestic converting industry mainly supplies basic PVC , while advanced structures like: PVC/PVDC high-barrier films PVC/PVDC/PE three layer high-barrier films Aclar (PCTFE) films Cold...
Post a Comment
Read more